GlassScriptPhysician profile
Colleen Bratsch
NPI 1154328060
$4,415.43
in general payments reported to CMS, 2019-2025
42 companies · $755 in 2025
The $755 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $546 · 2020: $493 · 2021: $633 · 2022: $702 · 2023: $749 · 2024: $538 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,021 · Education: $19.27 · Gift: $1.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,021.05 |
| Education | $19.27 |
| Gift | $1.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $708.89 | 2019-2023 | Orilissa, Lo Loestrin Fe, Ubrelvy |
| Bayer Healthcare Pharmaceuticals INC. | $414.16 | 2019-2025 | |
| Ascend Therapeutics US, LLC | $348.28 | 2020-2024 | |
| Organon LLC | $343.82 | 2021-2025 | Nexplanon, Jada System |
| Astellas Pharma US INC | $304.66 | 2019-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $274.64 | 2021-2025 | |
| Channel Medsystems, INC. | $250.75 | 2022-2023 | |
| Daiichi Sankyo INC. | $214.46 | 2019-2022 | |
| Sage Therapeutics, LLC | $177.41 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $128.95 | 2019-2025 | Paragard T 380a, Summit Doppler, Sos |
| Boston Scientific Corporation | $87.86 | 2022-2025 | Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous) |
| Merck Sharp & Dohme LLC | $85.18 | 2019-2022 | |
| Therapeuticsmd, INC. | $85.04 | 2020-2022 | |
| Millicent US INC | $77.01 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Myriad Women'S Health, INC. | $76.63 | 2023 | Myrisk |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Bratsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.